How Do I Know If My COVID Vaccine Side Effects Aren't Actually COVID? - Yahoo Lifestyle

If you're one of the 10 percent of Americans who have received the COVID vaccine, you may be concerned with side effects you've experienced like fatigue and chills.

How do you know if what you're feeling isn't actually COVID?

Shanthi Kappagoda, MD, an infectious-disease physician at Stanford Health Care, explained to POPSUGAR that a small percentage of people experience vaccine side effects such as injection-site reactions (redness or tenderness), fatigue, headaches, and chills, and a smaller number of people will have joint pain, fever, or swollen lymph nodes.

In general, she said, if you get the vaccine and then develop these symptoms one to three days after the vaccine, but you've been social distancing and mask wearing, most likely these are just side effects of the vaccine.

It is possible to contract COVID after the first or second dose of the vaccine; the vaccine is most effective after both shots, usually administered weeks apart.

If you get COVID after the first shot, Dr.

If I Have No COVID Vaccine Side Effects, Is the Vaccine Still Effective?

That means the vaccine is working, but could cause false alarm, so you should wait?

Just received your COVID-19 vaccine and suddenly have a headache.

COVID-19 vaccines from Pfizer and Moderna are already being distributed, which means vaccine side effects are a topic on everyone's minds.

As data continues to emerge, here's a look at what the numbers and experts are saying about the three vaccine candidates that are furthest along.

While enough supply doesn't mean everyone will actually be vaccinated by the end of May (the vaccines will still need to be shipped and distributed to patients, which takes time), that timeline is more hopeful than Biden's previous goal of July for full, nationwide supply.

At first, the COVID-19 vaccine felt like a light at the end of a tunnel.

Johnson & Johnson COVID-19 vaccine is approved And suddenly, there were three.

Food and Drug Administration authorized Johnson & Johnson’s COVID-19 vaccine, making it the first single-dose COVID-19 vaccine available in the U.S.

The Johnson Johnson vaccine "will save your life; it will keep you out of the hospital.".

A healthcare worker holds a dose of the Johnson & Johnson vaccine against the COVID-19 coronavirus as South Africa proceeds with its inoculation campaign at the Klerksdorp Hospital on February 18, 2021.

Food and Drug Administration authorized Johnson & Johnson’s one-shot COVID-19 vaccine for emergency use.

It’s now the third vaccine to be distributed across the nation, behind Moderna and Pfizer and their two-shot mRNA vaccines.

Nearly 4 million doses of the newly approved vaccine were shipped out across the country on Sunday night, the first dose of which is set to be administered Tuesday.

Deploying another vaccine will mean much to so many: to people itching to get a shot so they can see their grandkids; to the families of the more than 500,000 Americans who’ve died of COVID-19; but also, to the researchers and scientists who’ve worked tirelessly over the past year to help create a solution to our global crisis.

Hanneke Schuitemaker, PhD, the vice president and global head of viral vaccine discovery and translational medicine at Johnson & Johnson, is one of those researchers.

She helped develop the vaccine and has since been involved with analyzing the data from the Johnson & Johnson trials.

When her team released first released their phase three trial data showing their study determined the vaccine was safe and effective in January, I reached out to catch up.

in preventing symptomatic COVID.

“When we looked into the data more deeply, we realized that across countries and virus lineages, or variants, we have very high protection against severe COVID-19?

If we can prevent overwhelm with vaccines, we can save the population from the consequences and suffering of this pandemic.

Across the world I think we should do everything to get these vaccines to everybody.” Will the J&J vaccine help with that.

Not saying it shouldn’t be rolled out in the Western world, but I think it has potential to be rolled out in more challenging areas of the world especially, to bring the vaccine to everybody.” Have you had your vaccine.

I know you’ve worked in the past on other therapeutic vaccine candidates, like HIV, Ebola, and HPV.

Will you go back to that work or focus on new generations of COVID-19 vaccines.

But we’re also working on next generation COVID-19 vaccines.

We’ll do it unless we cannot, due to COVID restrictions.

How about some more R29 goodness, right here?Johnson & Johnson's One-Dose Vaccine FDA ApprovedHow Johnson & Johnson's Single-Shot Vaccine WorksWhy Are COVID Vaccines Only In Wealthy Communities.

The Novavax vaccine is among the first of the vaccines to demonstrate clinical efficacy against the original and both the U.K